Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Source BioScience reports further growth in interim statement

Source BioScience reports further growth in interim statement

28th November 2013

Source BioScience has highlighted its recent strong business performance for the first nine months of 2013 in its latest interim management statement.

During the third quarter of the year, the company's revenue was 20 percent higher than the corresponding period of last year, thanks to the ongoing success of its laboratory services activities, especially healthcare diagnostics and DNA sequencing.

The blood group serology reagents business acquired in April also achieved strong growth, while progress is being made on the integration of Vindon Healthcare following its 12.2 million pound acquisition.

With the launch of new products and services continuing apace and the company's recent geographical expansion efforts bearing fruit, prospects for 2014 and beyond are thought to be strong.

A company statement said: "Source BioScience has continued to deliver the rate of growth previously reported and we expect the momentum we have seen year to date from the underlying business to continue through the remainder of the year."

Source BioScience is looking to improve upon the eight per cent year-on-year growth it experienced during 2012.ADNFCR-8000103-ID-801666375-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.